Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.

[1]  C. B. Mishra,et al.  Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment. , 2017, Journal of medicinal chemistry.

[2]  S. M. Monti,et al.  Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors. , 2017, Bioorganic & medicinal chemistry.

[3]  C. Supuran.  Structure and function of carbonic anhydrases. , 2016, The Biochemical journal.

[4]  C. Supuran.  How many carbonic anhydrase inhibition mechanisms exist? , 2016, Journal of enzyme inhibition and medicinal chemistry.

[5]  C. Supuran,et al.  Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX. , 2015, Journal of medicinal chemistry.

[6]  C. Supuran,et al.  Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors , 2015, Journal of enzyme inhibition and medicinal chemistry.

[7]  C. Supuran,et al.  Carbonic anhydrase IX inhibitors in cancer therapy: an update. , 2015, Future medicinal chemistry.

[8]  Abdul-Malek S. Al-Tamimi,et al.  Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis , 2015, Journal of enzyme inhibition and medicinal chemistry.

[9]  C. Supuran,et al.  Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII) , 2015, Journal of enzyme inhibition and medicinal chemistry.

[10]  C. Supuran,et al.  New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII , 2015, Journal of enzyme inhibition and medicinal chemistry.

[11]  C. Supuran,et al.  Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests , 2015, Journal of enzyme inhibition and medicinal chemistry.

[12]  C. Supuran,et al.  Designing carbonic anhydrase inhibitors for the treatment of breast cancer , 2015, Expert opinion on drug discovery.

[13]  C. Supuran,et al.  The η-class carbonic anhydrases as drug targets for antimalarial agents , 2015, Expert opinion on therapeutic targets.

[14]  C. Supuran,et al.  Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates , 2015, Journal of enzyme inhibition and medicinal chemistry.

[15]  C. Supuran,et al.  Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site. , 2015, Journal of medicinal chemistry.

[16]  C. Supuran,et al.  Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors , 2015, Journal of enzyme inhibition and medicinal chemistry.

[17]  C. De Monte,et al.  Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme , 2015, Journal of enzyme inhibition and medicinal chemistry.

[18]  C. Supuran,et al.  Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases. , 2014, Bioorganic & medicinal chemistry letters.

[19]  C. Supuran,et al.  A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors. , 2014, Angewandte Chemie.

[20]  Giseli Capaci Rodrigues,et al.  Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease. , 2014, Journal of medicinal chemistry.

[21]  P. Lambin,et al.  Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates. , 2013, Journal of medicinal chemistry.

[22]  S. C. Chafe,et al.  Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche , 2013, Oncogene.

[23]  C. Supuran,et al.  Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. , 2013, Journal of medicinal chemistry.

[24]  C. Supuran,et al.  Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease. , 2013, Bioorganic & medicinal chemistry.

[25]  C. Supuran,et al.  A class of sulfonamides with strong inhibitory action against the α-carbonic anhydrase from Trypanosoma cruzi. , 2013, Journal of medicinal chemistry.

[26]  C. Supuran,et al.  Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors , 2013, Expert opinion on drug discovery.

[27]  C. Supuran,et al.  Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013) , 2013, Expert opinion on therapeutic patents.

[28]  Andrea Scozzafava,et al.  Antiobesity carbonic anhydrase inhibitors: a literature and patent review , 2013, Expert opinion on therapeutic patents.

[29]  C. Supuran,et al.  Anti-infective carbonic anhydrase inhibitors: a patent and literature review , 2013, Expert opinion on therapeutic patents.

[30]  C. Supuran,et al.  Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013) , 2013, Expert opinion on therapeutic patents.

[31]  C. Supuran,et al.  Antiglaucoma carbonic anhydrase inhibitors: a patent review , 2013, Expert opinion on therapeutic patents.

[32]  R. McKenna,et al.  Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review , 2013, Expert opinion on therapeutic patents.

[33]  A. Harris,et al.  New strategies for targeting the hypoxic tumour microenvironment in breast cancer. , 2013, Cancer treatment reviews.

[34]  Robert L. Arechederra,et al.  Effect of sulfonamides as carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion. , 2013, Bioorganic & medicinal chemistry.

[35]  C. Supuran.  Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture , 2013, Journal of enzyme inhibition and medicinal chemistry.

[36]  C. D. Boone,et al.  Structural annotation of human carbonic anhydrases , 2013, Journal of enzyme inhibition and medicinal chemistry.

[37]  C. Supuran,et al.  Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis , 2013, Journal of enzyme inhibition and medicinal chemistry.

[38]  A. Harris,et al.  Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro , 2013, Journal of enzyme inhibition and medicinal chemistry.

[39]  C. Supuran,et al.  Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids , 2013, Journal of enzyme inhibition and medicinal chemistry.

[40]  C. Supuran,et al.  Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases. , 2012, Chemical communications.

[41]  R. McKenna,et al.  Update on carbonic anhydrase inhibitors: a patent review (2008 – 2011) , 2012, Expert opinion on therapeutic patents.

[42]  C. Supuran,et al.  Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? , 2012, Chemical reviews.

[43]  C. Supuran,et al.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. , 2012, Journal of medicinal chemistry.

[44]  C. Supuran,et al.  A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology , 2012, Journal of enzyme inhibition and medicinal chemistry.

[45]  C. Supuran,et al.  Novel therapies for glaucoma: a patent review 2007 – 2011 , 2012, Expert opinion on therapeutic patents.

[46]  C. Supuran,et al.  Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. , 2011, Journal of medicinal chemistry.

[47]  Claudiu T. Supuran,et al.  Interfering with pH regulation in tumours as a therapeutic strategy , 2011, Nature Reviews Drug Discovery.

[48]  C. Supuran.  Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics? , 2011, Front. Pharmacol..

[49]  S. Leung,et al.  Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. , 2011, Cancer research.

[50]  C. Supuran,et al.  Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. , 2011, Journal of medicinal chemistry.

[51]  Y. Hsieh,et al.  Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. , 2010, European journal of cell biology.

[52]  K. Kaila,et al.  Acetazolamide and midazolam act synergistically to inhibit neuropathic pain , 2010, PAIN.

[53]  Claudiu T Supuran,et al.  Carbonic anhydrase inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[54]  P. Lambin,et al.  Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  J. Pastorek,et al.  Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features. , 2009, Journal of neurosurgery.

[56]  Pawel Swietach,et al.  The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths* , 2009, The Journal of Biological Chemistry.

[57]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. , 2009, Journal of medicinal chemistry.

[58]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications? , 2008, Organic & biomolecular chemistry.

[59]  Andrea Scozzafava,et al.  Carbonic anhydrase IX: A new druggable target for the design of antitumor agents , 2008, Medicinal research reviews.

[60]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[61]  H. Haapasalo,et al.  Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy. , 2007, Neuro-oncology.

[62]  C. Supuran,et al.  Carbonic anhydrase inhibitors as anticonvulsant agents. , 2007, Current topics in medicinal chemistry.

[63]  C. Supuran,et al.  The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents. , 2007, Current topics in medicinal chemistry.

[64]  C. Supuran,et al.  Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. , 2006, Bioorganic & medicinal chemistry letters.

[65]  C. Supuran,et al.  Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II , 2006 .

[66]  Katsuaki Sato,et al.  Carbonic Anhydrase II Is a Tumor Vessel Endothelium–Associated Antigen Targeted by Dendritic Cell Therapy , 2005, Clinical Cancer Research.

[67]  C. Supuran,et al.  Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. , 2005, Journal of medicinal chemistry.

[68]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. , 2005, Bioorganic & medicinal chemistry letters.

[69]  S. Chu,et al.  The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. , 2002, Cancer letters.

[70]  Luca Menabuoni,et al.  Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. , 2002, Journal of medicinal chemistry.

[71]  W. Sly,et al.  Expression of membrane-associated carbonic anhydrase XIV on neurons and axons in mouse and human brain. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[72]  W. Sly,et al.  Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[73]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? , 1999, Journal of medicinal chemistry.

[74]  C. Supuran,et al.  Carbonic anhydrase inhibitors - Part 57 : Quantum chemical QSAR of a group of 1,3,4-thiadiazole- and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties , 1999 .

[75]  C. Supuran,et al.  Carbonic anhydrase activators. Part 14. Syntheses of mono and bis pyridinium salt derivatives of 2-amino-5-(2-aminoethyl)- and 2-amino-5-(3-aminopropyl)-1,3,4-thiadiazole and their interaction with isozyme II , 1996 .

[76]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes* , 1996 .

[77]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes# , 1996 .

[78]  E. Hollande,et al.  The expression of carbonic anhydrases II and IV in the human pancreatic cancer cell line (Capan 1) is associated with bicarbonate ion channels , 1994, Biology of the cell.

[79]  R. Khalifah,et al.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.